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Meeting Report
To me, this has been one of the most inspiring 
meetings for a long time. Regularly attending 
the ASMS meeting is an essential experience 
in proteomics. Yet even after years of doing so 
it is difficult not to be stunned and simultane-
ously be paralyzed by its now 6277 participants, 
2998 posters and up to eight parallel sessions 
(ASMS 2012). The European Proteomics 
Association (EuPA) conference 2012 was more 
tailored to networking. With 393 participants, 
262 posters and only one session at a time one 
could actually meet people multiple times. 
The organi zers had attracted some of the best 
emerging scientists in the field that Europe can 
muster. Quite possibly, this is the best meet-
ing for PhD students to hunt for an exciting 
proteomics postdoc position. I personally did 
not miss a dominance of political heavy weights 
and scientific super heroes. Adjectives to my lik-
ing are cool and hip as well as raw, hungry and 
searching.
Cross-linking/mass spectrometry as an 
emerging field
My personal highlight: The Workshop ‘Cross-
linking/mass spectrometry’ with James Bruce 
(University of Washington, WA, USA), Florian 
Stengel (Aebersold laboratory, ETH Zurich, 
Switzerland) and Zhuo Angel Chen (Rappsilber 
laboratory, University of Edinburgh, UK, and 
TU Berlin, Germany) possibly marked the 
endpoint of four decades of frustration. Cross-
linking may be one of the oldest biochemical 
tools for the investigation of protein interactions 
and structure [1]. It certainly has not been one 
of the most successful ones for long. Even if 
you have tried it few years ago, likely you have 
been disappointed by elusive cross-links that 
did not yield to mass spectrometric detection. 
Early departures from this, certainly in wealth of 
data, include analyses of multiprotein complexes 
such as Nup84c (four subunits, 180 kDa [2]), Pol 
II (12 subunits, 500 kDa [3]) and Pol II-TFIIF 
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Cross-linking/mass spectrometry ended decades of method developments and entered the era 
of applications at this year’s European Proteomics Association meeting. The train has started 
moving, with successful applications of this tool by multiple pioneering laboratories addressing 
biological and structural problems. Proteomics, on the other side, sees ever increasing data 
volumes, leading to questions as to how to store the data mountain publically, use it and 
convert it into testable hypotheses. The European Proteomics Association meeting has been 
complementary to the American Society for Mass Spectrometry meeting in many ways, also 
thanks to its more manageable size and the vision of the organizers in inviting some of Europe’s 
best emerging minds.
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(15 subunits, 670 kDa [3]). Moving on, data on the proteasome 
(33 different prot-eins, 47 subunits, 2.5 MDa) helped to model 
high-resolution structures into a cryoEM map [4]. In a handful of 
laboratories the tool has matured in parallel, to a level that now 
allows routine use in structural and mechanistic research.
Florian Stengel showed in Glasgow how cross-link data could 
even correct the incorrect sub unit arrangement of a crystal struc-
ture [5]. This somewhat surprising initial arrangement in the 
TRiC/CCT complex was the result of the high similarity of the 
subunits involved and low resolution of the original EM densities 
and crystal diffractions. Ultimately, integrated structural biology 
is the way forward to study multiprotein complexes, using any 
data available [6]. Making use of cross-link constraints, such as 
providing peptide-level resolution, thus fills the gap between high 
and low resolution methods [1].
James Bruce, a pioneer of complex mixture analysis by cross-
linking/mass spectrometry [7–9], stretched the vision of cross-
linking/mass spectrometry to in vivo analyses of Escherichia coli 
and human cells. He reported the impressive number of over 
1000 observed cross-links in either. Of course, the tip of the inter-
actome iceberg may still hardly be scratched. Still, add the nearly 
7000 cross-links reported by the Rappsilber lab in the ‘Chemical 
Proteomics’ session for the less complex Mycoplasma pneumoniae 
lysate and it may become clear, nevertheless, that even smaller but 
still complex heterogeneous structures and networks are starting 
to fall within reach of this tool. The challenge now will be for 
the pioneers to obtain ever more data in whole cell lysates or from 
intact cells. However, the tools are solidly established already and 
wait for adaptation by other laboratories for more routine, but 
possibly also biologically more exiting mechanistic studies.
In theme with the workshop, Ruedi Aebersold (ETH Zurich, 
Switzerland), a member of the League of Extraordinary Gentlemen 
in proteomics, presented such a biological showcase of cross-link-
ing/mass spectrometry during his award talk as the EuPA Senior 
Scientist 2012. He gave a thrilling outlook into what may happen 
soon in many molecular biology laboratories around the globe 
when combining cross-linking/mass spectrometry with bead-based 
isolation of protein complexes. This is also backed by independent 
work from the Rappsilber laboratory by Zhuo Angel Chen [10].
Adding quantitation, Zhuo Angel Chen presented in the work-
shop the use of isotope labeled cross-linkers to study conformation 
changes of proteins. She focused on the human complement system 
as a conformation-controlled network and proposed the domain 
arrangement of complement C3(H
2
O) based on cross-link data and 
available crystal structures of two conformers with different PTM 
status, C3 and C3b. Exciting times are ahead and the number of 
possible applications of cross-linking/mass spectrometry are count-
less. I foresee a great future for cross-linking/mass spectrometry 
as an emerging field and I look forward to a culture in which key 
developments and  inspirations by others are acknowledged and 
embraced.
Transforming data mountains into hypotheses
Rune Linding (Technical University of Denmark) presented 
an awe-inspiring conversion of proteomic data mountains into 
information mountains, requiring multiple dedicated experimen-
tal and computational tools, for example, NetworKIN [11] besides 
mass spectrometers and expertise from informatics to medicine. 
The emerging field of network medicine is taking off and pro-
teomics is playing a central role in that [12]. While such studies 
may require multidisciplinary specialized environments they are 
archetypical to what is happening to large parts of biological sci-
ence in order to address some of the big questions. An interesting 
discussion followed, seeing biology as the new physics by relying 
on large teams of scientists that, indeed, may need a different 
publication model. Pubmed knows only one first and one last 
author regardless of how many stars are given for equal contribu-
tion and shared communication. Is big science in biology driving 
students and postdocs out of their careers as only one can be first 
author? Maybe there is more to be learned from physics, besides 
teamwork leading up to a publication.
Regardless of its impact, the fate of mass spectrometric data is cur-
rently all too often inaccessibility and being lost. A team of scientists 
spearheaded by the EBI is working on PRIDE, a prote omics data 
repository, to address this [13]. While uploads may have been cumber-
some in the past, new data analysis tools allow direct interaction with 
PRIDE. For example, Lennart Martens’ group (Ghent University, 
Belgium) presented integrative tools with an extensive user interface 
that allow using multiple search tools (OMSSA, XTandem, Mascot) 
in one analysis and presenting the combined results to the user in 
an interactive analysis environment with one-click submission to 
PRIDE. Check out SearchGUI [14] and PeptideShaker [101]. Angus 
Lamond’s laboratory (University of Dundee, UK) is going one step 
further and has created a repository that stores all of their experi-
mental data together with detailed metadata annotations for integra-
tive exploration. Angus announced that this ‘PepTracker’ software 
[102] is currently being tested at the University of Dundee and will 
soon be available for general distribution. This creates a basis for 
‘super experiments’, where the integration of richly annotated data 
and results from many separate experiments reveals new relation-
ships between proteins and cellular mechanisms and can generate 
hypotheses that were not foreseen in the design of any of the original 
experiments [15,16]. Meta-analyses, such as those used to define func-
tionally interesting proteins in mitotic chromosomes [17], often rely 
on machine learning. As the analysis challenge of identifying and 
quantifying proteins is slowly being addressed, the focus of bioinfor-
maticians will shift increasingly towards data integrating approaches 
for hypothesis generation. This will likely shift job descriptions in 
proteomics from mass spectrometry experience to data handling 
and hypothesis generation skills. Students are well advised to pre-
pare through adequate choice of courses and more computational 
researchers will  (hopefully) make their way into biology.
An integrated EuPA vision
The EuPA congress organizers focused on emerging science and 
scientists, giving this meeting a fresh and unique feel. EuPA could 
consider picking up on this vision by also awarding an ‘Emerging 
Scientist’ prize. I argue here that this would have a larger impact 
on European proteomics than any other prize, senior or junior.




consolidation phase; junior funding sees its ends and senior 
funding is only a hope on the horizon. This is the point when a 
scientist must show vision yet sees it confronted with the often 
too conservative thinking of journals and/or funding agencies. 
The field could strengthen the backing of mid-career scientists 
by a solid slap on the shoulder and a ‘carry on, we see that you 
are heading in the right direction’, just before mid-career turns 
into fame. For EuPA, in awards and its congress, a key aim might 
become to scout for and foster budding and emerging talent.
To poster authors
A comment on the more technical side, poster authors may want 
to have a look at some of the company posters. Some of the clearest 
posters came from companies. I would advise students to pair up 
and measure the time it takes one of them to extract a message 
from a poster that they can explain to the other. If it takes more 
than 10 s for a first idea, the poster is poorly made. It took me 
about that time to see that poster 1 [18] had niftily exploited high 
MS2 resolution and the mass difference between 15N and 13C to 
increase the multiplexing of TMT after two of the TMT reagents 
saw a change in their labeling scheme most recently. My prize 
for the most original poster design would go to the laboratory 
of Concha Gil [103]. Even if it took me much longer than 10 s to 
extract content from their posters, they have my vote for being 
refreshingly  different. See for yourself when you get a chance.
As workshop organizer, speaker, session head and poster prize 
judge I possibly came closest to being an organizer without actu-
ally having been one. I was given these pages to give a personal 
account of this year’s EuPA meeting. I apologize for my very 
subjective take on the meeting and to all those colleagues whose 
work I did not mention in this report. The French Electrophoresis 
and Proteomics Society [104] will host the 7th EuPA Congress in 
Saint Malo, France, in 2013.
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